IVC Wealth Advisors LLC Trims Position in The Clorox Company (NYSE:CLX)

IVC Wealth Advisors LLC reduced its holdings in The Clorox Company (NYSE:CLX) by 9.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,522 shares of the company’s stock after selling 265 shares during the quarter. IVC Wealth Advisors LLC’s holdings in Clorox were worth $410,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in CLX. State Street Corp increased its stake in shares of Clorox by 3.1% during the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after acquiring an additional 245,525 shares during the last quarter. Mizuho Securities USA LLC increased its position in Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Geode Capital Management LLC raised its stake in Clorox by 1.1% during the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after purchasing an additional 33,970 shares during the period. Stifel Financial Corp boosted its holdings in shares of Clorox by 1.7% in the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after purchasing an additional 37,967 shares during the last quarter. Finally, Van ECK Associates Corp grew its stake in shares of Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after buying an additional 31,510 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Trading Up 1.3 %

Shares of CLX opened at $160.81 on Friday. The stock has a 50-day moving average price of $163.93 and a 200 day moving average price of $157.11. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The company has a market capitalization of $19.90 billion, a P/E ratio of 56.03, a P/E/G ratio of 2.95 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the company posted $0.49 earnings per share. The company’s quarterly revenue was up 27.0% compared to the same quarter last year. Sell-side analysts forecast that The Clorox Company will post 6.87 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.03%. Clorox’s payout ratio is currently 170.04%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Barclays cut their target price on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research report on Friday, January 17th. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $155.00 to $157.00 in a research note on Tuesday, January 7th. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and lifted their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Finally, DA Davidson increased their price objective on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.